Pnd8 Medical Costs Associated Withtreatment Change In Multiple SclerosisNordstrom · Value in Health2008PDF92 KB
PND8 Prevalence and Incidence Rates of Multiple Sclerosis in the United StatesBaser · Value in Health2012PDF60 KB
Pnd8 Cost-effectiveness Analysis Of Rebif In First-line Relapsing Remitting Multiple Sclerosis In GermanyNuijten · Value in Health2008PDF78 KB
PND8 INCIDENCE RATES OF SUBARACHNOID HEMORRHAGE IN PATIENTS WITH UNRUPTURED ANEURYSM IN SOUTH KOREA FROM 2006-2009Lee · Value in Health2011PDF56 KB
PND8 Economic Evaluation of Clinical Pathways Management for Cerebral Infarction in RURAL Area of ChinaWudong · Value in Health Regional Issues2020PDF716 KB
Pnd8 Cost-effectiveness Of Treating Restless Legs Patients With Pramipexole Compared To No Treatment In SwedenLees · Value in Health2006PDF72 KB
Pnd8 A Systematic Literature Review Of Efficacy And Safety Of Disease Modifying Therapies (dmts) In Secondary Progressive Multiple SclerosisThakur · Value in Health2019PDF380 KB
PND8 Potential Economic Benefits of Pegylation in the Treatment of Multiple Sclerosis: A Systematic Review of the Pharmacoeconomic LiteratureBecker · Value in Health2012PDF57 KB
Pnd8 Approach To Matching Alzheimer's Disease Patients And Their Spouses To Assess Caregiver Burden In An Administrative Claims DatabaseBrixner · Value in Health2010PDF77 KB
PND8 ANALISIS DE MINIMIZACION DE COSTOS DE TOXINA ONABOTULINICA A 100 U EN PACIENTES CON BLEFAROESPASMO Y TORTICOLIS ESPASMODICAMolina et al. · Value in Health Regional Issues2019PDF316 KB
Pnd8: Implications Of Prescribing For Patients With Relapsing-remitting Multiple Sclerosis (rrms): Introducing A Treatment Algorithm For Glatiramer Acetate (copaxone)Brambleby · Value in Health2001PDF53 KB